Intellectual Property India Publishes Patent Application for 'Cd25-Specific Antibodies And Uses Thereof' Filed by The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517002483 A) filed by The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Bethesda, U.S.A., on Jan. 10, for 'cd25-specific antibodies and uses thereof.'

Inventor(s) include Kobayashi, Hisataka; and Choyke, Peter L.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "Monoclonal antibodies that specifically bind CD25, as well as conjugates of the anti-CD25 antibodies, are described. The CD25-specific monoclonal antibodies and conjugates thereof do not block binding of IL- 2 to CD25 and induce litt...